SEARCH

SEARCH BY CITATION

References

  • ADAM, D., ADAMKLAGES, S. & KRONKE, M. (1996). Identification of p55 tumor necrosis factor receptor-associated proteins that couple to signaling pathways not initiated by the death domain. J. Inflamm., 47, 6166.
  • ADAM, D., RUFF, A., STRELOW, A., WIEGMANN, K. & KRONKE, M. (1998). Induction of stress-activated protein kinases c-Jun N-terminal kinases by the p55 tumour necrosis factor receptor does not require sphingomyelinases. Biochem. J., 333, 343350.
  • ADAMKLAGES, S., SCHWANDNER, R., ADAM, D., KREDER, D., BERNARDO, K. & KRONKE, M. (1998a). Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J. Leukoc. Biol., 63, 678682.
  • ADAMKLAGES, S., SCHWANDNER, R., LUSCHEN, S., USSAT, S., KREDER, D. & KRONKE, M. (1998b). Caspase-mediated inhibition of human cytosolic phospholipase A2 during apoptosis. J. Immunol., 161, 56875694.
  • AGGARWAL, B.B. (2000). Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-κB. Ann. Rheum. Dis., 59, 616.
  • AMRANI, Y., LAZAAR, A.L., HOFFMAN, R., AMIN, K., OUSMER, S. & PANETTIERI, R.A. (2000). Activation of p55 tumor necrosis factor-α receptor-1 coupled to tumor necrosis factor receptor-associated factor 2 stimulates intercellular adhesion molecule-1 expression by modulating a thapsigargin-sensitive pathway in human tracheal smooth muscle cells. Mol. Pharmacol., 58, 237245.
  • AMRANI, Y., LAZAAR, A.L. & PANETTIERI, R.A. (1999). Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-κB-dependent signaling pathway that is only partially sensitive to dexamethasone. J. Immunol., 163, 21282134.
  • AMRANI, Y., MARTINET, N. & BRONNER, C. (1995). Potentiation by tumor-necrosis-factor-α of calcium signals induced by bradykinin and carbachol in human tracheal smooth-muscle cells. Br. J. Pharmacol., 114, 45.
  • AMRANI, Y., PANETTIERI, R.A., FROSSARD, N. & BRONNER, C. (1996). Activation of the TNF α-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Am. J. Respir. Cell Mol. Biol., 15, 5563.
  • ATSUMI, G., TAJIMA, M., HADANO, A., NAKATANI, Y., MURAKAMI, M. & KUDO, I. (1998). Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2 which undergoes proteolytic inactivation. J. Biol. Chem., 273, 1387013877.
  • BAR-SAGI, D. & HALL, A. (2000). Ras and rho GTPases: a family reunion. Cell, 103, 227238.
  • BARBER, S.A., PERERA, P.Y., MCNALLY, R. & VOGEL, S.N. (1995). The serine threonine phosphatase inhibitor, calyculin-a, inhibits and dissociates macrophage responses to lipopolysaccharide. J. Immunol., 155, 14041410.
  • BARONE, F.C., IRVING, E.A., RAY, A.M., LEE, J.C., KASSIS, S., KUMAR, S., BADGER, A.M., LEGOS, J.J., ERHARDT, J.A., OHLSTEIN, E.H., HUNTER, A.J., HARRISON, D.C., PHILPOTT, K., SMITH, B.R., ADAMS, J.L. & PARSONS, A.A. (2001). Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev., 21, 129145.
  • BASU, S., BAYOUMY, S., ZHANG, Y., LOZANO, J. & KOLESNICK, R. (1998). Bad enables ceramide to signal apoptosis via ras and raf-1. J. Biol. Chem., 273, 3041930426.
  • BAUD, V., LIU, Z.-G., BENNETT, B., SUZUKI, N., XIA, Y. & KARIN, M. (1999). Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev., 13, 12971308.
  • BAXTER, G.T., KUO, R.C., JUPP, O.J., VANDENABEELE, P. & MACEWAN, D.J. (1999). Tumor necrosis factor-α mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J. Biol. Chem., 274, 95399547.
  • BERMUDEZ, L.E. & YOUNG, L.S. (1987). Tumor-necrosis-factor (TNF) activates macrophages (MO) to kill mycobacterium-avium complex (MAC) by a protein-kinase C-(PKC)-independent pathway. J. Leukoc. Biol., 42, 598599.
  • BERRA, E., DIAZMECO, M.T., LOZANO, J., FRUTOS, S., MUNICIO, M.M., SANCHEZ, P., SANZ, L. & MOSCAT, J. (1995). Evidence for a role of MEK and MAPK during signal transduction by protein kinase C ζ. EMBO J., 14, 61576163.
  • BEUTLER, B., GREENWALD, D., HULMES, J.D., CHANG, M., PAN, Y.C.E., MATHISON, J., ULEVITCH, R. & CERAMI, A. (1985). Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature, 316, 552554.
  • BEYAERT, R., CUENDA, A., VANDENBERGHE, W., PLAISANCE, S., LEE, J.C., HAEGEMAN, G., COHEN, P. & FIERS, W. (1996). The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor. EMBO J., 15, 19141923.
  • BEYAERT, R., HEYNINCK, K., DEVALCK, D., BOEYKENS, F., VANROY, F. & FIERS, W. (1993). Enhancement of tumor-necrosis-factor cytotoxicity by lithium-chloride is associated with increased inositol phosphate accumulation. J. Immunol., 151, 291300.
  • BEYAERT, R., SUFFYS, P., VANROY, F. & FIERS, W. (1987). Inhibition of TNF cytotoxicity by protease inhibitors. Immunobiology, 175, 3.
  • BICK, R.J., LIAO, J.P., KING, T.W., LEMAISTRE, A., MCMILLIN, J.B. & BUJA, L.M. (1997). Temporal effects of cytokines on neonatal cardiac myocyte Ca2+ transients and adenylate cyclase activity. Am. J. Physiol.-Heart Circ. Physiol., 41, H1937H1944.
  • BIRD, T.A., KYRIAKIS, J.M., TYSHLER, L., GAYLE, M., MILNE, A. & VIRCA, G.D. (1994). Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase kinase stress-activated protein-kinase by a pathway that is independent of p21ras, raf-1, and MAP kinase kinase. J. Biol. Chem., 269, 3183631844.
  • BODIE, S.L., FORD, I., GREAVES, M. & NIXON, G.F. (2001). Thrombin-induced activation of rhoA in platelet shape change. Biochem. Biophys. Res. Commun., 287, 7176.
  • BOLGER, A.P. & ANKER, S.D. (2000). Tumour necrosis factor in chronic heart failure – a peripheral view on pathogenesis, clinical manifestations and therapeutic implications. Drugs, 60, 12451257.
  • BONIZZI, G., PIETTE, J., SCHOONBROODT, S., MERVILLE, M.P. & BOURS, V. (1999). Role of the protein kinase C λ/ι isoform in nuclear factor-κB activation by interleukin-1 β or tumor necrosis factor-α: cell type specificities. Biochem. Pharmacol., 57, 713720.
  • BOONE, E., VANDEVOORDE, V., DEWILDE, G. & HAEGEMAN, G. (1998). Activation of p42/p44 mitogen-activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55-kDa TNF receptor. FEBS Lett., 441, 275280.
  • BORSCHHAUBOLD, A.G., BARTOLI, F., ASSELIN, J., DUDLER, T., KRAMER, R.M., APITZCASTRO, R., WATSON, S.P. & GELB, M.H. (1998). Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells. J. Biol. Chem., 273, 44494458.
  • BORSCHHAUBOLD, A.G., KRAMER, R.M. & WATSON, S.P. (1997). Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur. J. Biochem., 245, 751759.
  • BORSET, M., MEDVEDEV, A.E., SUNDAN, A. & ESPEVIK, T. (1996). The role of the two TNF receptors in proliferation, NF-κB activation and discrimination between TNF and LTα signalling in the human myeloma cell line OH-2. Cytokine, 8, 430438.
  • BOZYCZKO-COYNE, D., O'KANE, T.M., WU, Z.L., DOBRZANSKI, P., MURTHY, S., VAUGHT, J.L. & SCOTT, R.W. (2001). CEP-1347/KT-7515, An inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with a β-induced cortical neuron apoptosis. J. Neurochem., 77, 849863.
  • BRANELLEC, D., DECREMOUX, P., BARREAU, P., CALVO, F. & CHOUAIB, S. (1992). Tumor necrosis factor-mediated cell-lysis in vitro – relationship to camp accumulation and guanine nucleotide-binding proteins. Eur. J. Immunol., 22, 963967.
  • BRINKMAN, B.M.N., TELLIEZ, J.B., SCHIEVELLA, A.R., LIN, L.L. & GOLDFELD, A.E. (1999). Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2 and p38 mitogen-activated protein kinase-dependent TNF-α gene expression. J. Biol. Chem., 274, 3088230886.
  • CARSWELL, E.A., OLD, L.J., KASSEL, R.L., GREEN, S., FIORE, N. & WILLIAMSON, B. (1975). An endotoxin-induced serum factor that causes necrosis of tumours. Proc. Natl. Acad. Sci. U.S.A, 72, 36663670.
  • CASTELLINO, A.M., PARKER, G.J., BORONENKOV, I.V., ANDERSON, R.A. & CHAO, M.V. (1997). A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase. J. Biol. Chem., 272, 58615870.
  • CHAN, F.K.M., CHUN, H.J., ZHENG, L.X., SIEGEL, R.M., BUI, K.L. & LENARDO, M.J. (2000). A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science, 288, 23512354.
  • CHANG, D.J., RINGOLD, G.M. & HELLER, R.A. (1992). Cell killing and induction of manganous superoxide-dismutase by tumor-necrosis-factor-α is mediated by lipoxygenase metabolities of arachidonic-acid. Biochem. Biophys. Res. Commun., 188, 538546.
  • CHANG, N.S. (2000). TGF-β-induced matrix proteins inhibit p42/44 MAPK and JNK activation and suppress TNF-mediated i κ b α degradation and NF-κB nuclear translocation in L929 fibroblasts. Biochem. Biophys. Res. Commun., 267, 194200.
  • CHAO, D.T. & KORSMEYER, S.J. (1998). Bcl-2 family: regulators of cell death. Ann. Rev. Immunol., 16, 395419.
  • CHINNAIYAN, A.M., O'ROURKE, K., TEWARI, M. & DIXIT, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505512.
  • CLARK, J.D., LIN, L.L., KRIZ, R.W., RAMESHA, C.S., SULTZMAN, L.A., LIN, A.Y., MILONA, N. & KNOPF, J.L. (1991). A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+– dependent translocation domain with homology to PKC and GAP. Cell, 65, 10431051.
  • CLARK, M.A., CHEN, M.J. & BOMALASKI, J.S. (1987). Tumor-necrosis-factor induces phospholipase-A2 activity and the synthesis of a phospholipase-A2 activating protein (PLAP) in endothelial-cells. Fed. Proc., 46, 1946.
  • COHEN, G.M. (1997). Caspases: the executioners of apoptosis. Biochem. J., 326, 116.
  • CONWAY, A.M., PYNE, N.J. & PYNE, S. (2000). Ceramide-dependent regulation of p42/p44 mitogen-activated protein kinase and c-Jun N-terminal-directed protein kinase in cultured airway smooth muscle cells. Cell. Signal., 12, 737743.
  • CORONEOS, E., WANG, Y.Z., PANUSKA, J.R., TEMPLETON, D.J. & KESTER, M. (1996). Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase Cascades. Biochem. J., 316, 1317.
  • COTTIN, V., VAN LINDEN, A. & RICHES, D.W.H. (1999). Phosphorylation of tumor necrosis factor receptor CD120a (p55) by p42(MAPK/ERK2) induces changes in its subcellular localization. J. Biol. Chem., 274, 3297532987.
  • COURIEL, D.R., HICKS, K., GIRALT, S. & CHAMPLIN, R.E. (2000). Role of tumor necrosis factor-α inhibition with infliximAb in cancer therapy and hematopoietic stem cell transplantation. Curr. Opin. Oncol., 12, 582587.
  • CROSS, T.G., SCHEEL-TOELLNER, D., HENRIQUEZ, N.V., DEACON, E., SALMON, M. & LORD, J.M. (2000). Serine/threonine protein kinases and apoptosis. Exp. Cell Res., 256, 3441.
  • CUNNINGHAM, A.J., MURRAY, C.A., ONEILL, L.A.J., LYNCH, M.A. & OCONNOR, J.J. (1996). Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett., 203, 1720.
  • CUVILLIER, O., PIRIANOV, G., KLEUSER, B., VANEK, P.G., COSO, O.A., GUTKIND, J.S. & SPIEGEL, S. (1996). Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature, 381, 800803.
  • DAI, Y., YU, C.R., SINGH, V., TANG, L., WANG, Z.L., MCINISTRY, R., DENT, P. & GRANT, S. (2001). Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells. Cancer Res., 61, 51065115.
  • DARNAY, B.G. & AGGARWAL, B.B. (1997). Inhibition of protein tyrosine phosphatases causes phosphorylation of tyrosine-331 in the p60 TNF receptor and inactivates the receptor-associated kinase. FEBS Lett., 410, 361367.
  • DARNAY, B.G. & AGGARWAL, B.B. (1999). Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors. Ann. Rheum. Dis., 58, 213.
  • DARNAY, B.G., REDDY, S.A.G. & AGGARWAL, B.B. (1994). Physical and functional association of a serine-threonine protein-kinase to the cytoplasmic domain of the p80 form of the human tumor- necrosis-factor receptor in human histiocytic lymphoma U-937 cells. J. Biol. Chem., 269, 1968719690.
  • DARNAY, B.G., SINGH, S. & AGGARWAL, B.B. (1997). The p80 TNF receptor-associated kinase (p80TRAK) associates with residues 354-397 of the p80 cytoplasmic domain: similarity to casein kinase. FEBS Lett., 406, 101105.
  • DAVIS, R.J. (1999). Signal transduction by the c-Jun N-terminal kinase. Cell. Responses Stress, 112.
  • DAYER, J.M., BEUTLER, B. & CERAMI, A. (1985). Cachectin tumor necrosis factor stimulates collagenase and prostaglandin-E2 production by human synovial-cells and dermal fibroblasts. J. Exp. Med., 162, 21632168.
  • DECLERCQ, W., DENECKER, G., FIERS, W. & VANDENABEELE, P. (1998). Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J. Immunol., 161, 390399.
  • DECLERCQ, W., VANDENABEELE, P. & FIERS, W. (1995). Dimerization of chimeric erythropoietin 75 kDa tumor-necrosis-factor (TNF) receptors transduces TNF signals – necessity for the 75 kDa TNF-Receptor transmembrane domain. Cytokine, 7, 701709.
  • DECOSTER, E., VANHAESEBROECK, B., VANDENABEELE, P., GROOTEN, J. & FIERS, W. (1995). Generation and biological characterization of membrane-bound, uncleavable murine tumor-necrosis-factor. J. Biol. Chem., 270, 1847318478.
  • DENECKER, G., VANDENABEELE, P., GROOTEN, J., PENNING, L.C., DECLERCQ, W., BEYAERT, R., BUURMAN, W.A. & FIERS, W. (1997). Differential role of calcium in tumour necrosis factor-mediated apoptosis and secretion of granulocyte-macrophage colony-stimulating factor in a T cell hybridoma. Cytokine, 9, 631638.
  • DENECKER, G., VERCAMMEN, D., DECLERCQ, W. & VANDENABEELE, P. (2001). Apoptotic and necrotic cell death induced by death domain receptors. Cell. Mol. Life Sci., 58, 356370.
  • DEVALCK, D., VERCAMMEN, D., FIERS, W. & BEYAERT, R. (1998). Differential activation of phospholipases during necrosis or apoptosis: a comparative study using tumor necrosis factor and anti- Fas antibodies. J. Cell. Biochem., 71, 392399.
  • DEVIN, A., COOK, A., LIN, Y., RODRIGUEZ, Y., KELLIHER, M. & LIU, Z.G. (2000). The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity, 12, 419429.
  • DHAWAN, S., SINGH, S. & AGGARWAL, B.B. (1997). Induction of endothelial cell surface molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-κB. Eur. J. Immunol., 27, 21722179.
  • DIAZ, F. & BOURGUIGNON, L.Y.W. (2000). Selective down-regulation of ip3 receptor subtypes of caspases and calpain during TNF α-induced apoptosis of human T-lymphoma cells. Cell Calcium, 27, 315328.
  • DIAZMECO, M.T., LOZANO, J., MUNICIO, M.M., BERRA, E., FRUTOS, S., SANZ, L. & MOSCAT, J. (1994). Evidence for the in-vitro and in-vivo interaction of ras with protein-kinase-c-ζ. J. Biol. Chem., 269, 3170631710.
  • DIGEL, W., PORZSOLT, F., SCHMID, M., HERRMANN, F., LESSLAUER, W. & BROCKHAUS, M. (1992). High-levels of circulating soluble receptors for tumor-necrosis-factor in hairy-cell leukemia and type-B chronic lymphocytic-leukemia. J. Clin. Invest., 89, 16901693.
  • DOBROWSKY, R.T., KAMIBAYASHI, C., MUMBY, M.C. & HANNUN, Y.A. (1993). Ceramide activates heterotrimeric protein phosphatase-2a. J. Biol. Chem., 268, 1552315530.
  • DOMAN, R.K., PEREZ, M. & DONATO, N.J. (1999). JNK and p53 stress signaling cascades are altered in MCF-7 cells resistant to tumor necrosis factor-mediated apoptosis. J. Interferon Cytokine Res., 19, 261269.
  • DOUGALL, W.C., GLACCUM, M., CHARRIER, K., ROHRBACH, K., BRASEL, K., DE SMEDT, T., DARO, E., SMITH, J., TOMETSKO, M.E., MALISZEWSKI, C.R., ARMSTRONG, A., SHEN, V., BAIN, S., COSMAN, D., ANDERSON, D., MORRISSEY, P.J., PESCHON, J.J. & SCHUH, J. (1999). RANK is essential for osteoclast and lymph node development. Genes Dev., 13, 24122424.
  • DOUNI, E. & KOLLIAS, G. (1998). A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin α, or the p55TNF-R. J. Exp. Med., 188, 13431352.
  • DRESSLER, K.A., MATHIAS, S. & KOLESNICK, R.N. (1992). Tumor-necrosis-factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science, 255, 17151718.
  • DRUMMOND, M.W. & HOLYOAKE, T.L. (2001). Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good? Blood Rev., 15, 8595.
  • ELIOPOULOS, A.G., GALLAGHER, N.J., BLAKE, S.M.S., DAWSON, C.W. & YOUNG, L.S. (1999). Activation of the p38 mitogen-activated protein kinase pathway by epstein-barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem., 274, 1608516096.
  • ENSLEN, H., RAINGEAUD, J. & DAVIS, R.J. (1998). Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem., 273, 17411748.
  • ERICKSON, S.L., DESAUVAGE, F.J., KIKLY, K., CARVERMOORE, K., PITTSMEEK, S., GILLETT, N., SHEEHAN, K.C.F., SCHREIBER, R.D., GOEDDEL, D.V. & MOORE, M.W. (1994). Decreased sensitivity to tumor-necrosis-factor but normal T-cell development in TNF receptor-2-deficient mice. Nature, 372, 560563.
  • ERMAKOVA, N.V., PAULSSEN, R.H. & FLORHOLMEN, J. (1999). The effect of TNF-α on cell growth and PLC-γ expression in insulin-secreting β-cells. Diabetologia, 42, 529.
  • ESTROV, Z., MANNA, S.K., HARRIS, D., VAN, Q., ESTEY, E.H., KANTARJIAN, H.M., TALPAZ, M. & AGGARWAL, B.B. (1999). Phenylarsine oxide blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, and induces apoptosis of actue myelogenous leukemia cells. Blood, 94, 28442853.
  • FELDMANN, M. & MAINI, R.N. (2001). Anti-TNFα therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol., 19, 163196.
  • FERNANDEZ-BOTRAN, R. (2000). Soluble cytokine receptors: novel immunotherapeutic agents. Expert Opin. Investigational Drugs, 9, 497514.
  • FERRARI, R. (1999). The role of TNF in cardiovascular disease. Pharmacol. Res., 40, 97105.
  • FIERS, W., BEYAERT, R., BOONE, E., CORNELIS, S., DECLERCQ, W., DECOSTER, E., DENECKER, G., DEPUYDT, B., DEVALCK, D., DEWILDE, G., GOOSSENS, V., GROOTEN, J., HAEGEMAN, G., HEYNINCK, K., PENNING, L., PLAISANCE, S., VANCOMPERNOLLE, K., VANCRIEKINGE, W., VANDENABEELE, P., VANDENBERGHE, W., VANDECRAEN, M., VANDEVOORDE, V. & VERCAMMEN, D. (1996). TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J. Inflamm., 47, 6775.
  • FONG, C.W., ZHANG, Y., NEO, S.Y. & LIN, S.C. (2000). Specific induction of rgs 16 (regulator of G-protein signalling 16) mRNA by protein kinase C in CEM leukaemia cells is mediated via tumour necrosis factor α in a calcium-sensitive manner. Biochem. J., 352, 747753.
  • GESCHER, A. (2000). Staurosporine analogues – pharmacological toys or useful antitumour agents? Crit. Rev. Oncol. Hematol., 34, 127135.
  • GODFREY, R.W., JOHNSON, W.J. & HOFFSTEIN, S.T. (1987). Recombinant tumor-necrosis-factor and interleukin-1 both stimulate human synovial cell arachidonic-acid release and phospholipid-metabolism. Biochem. Biophys. Res. Commun., 142, 235241.
  • GONG, M.C., IIZUKA, K., NIXON, G., BROWNE, J.P., HALL, A., ECCLESTON, J.F., SUGAI, M., KOBAYASHI, S., SOMLYO, A.V. & SOMLYO, A.P. (1996). Role of guanine nucleotide-binding proteins ras-family or trimeric proteins or both in Ca2+ sensitization of smooth muscle. Proc. Natl. Acad. Sci. U.S.A., 93, 13401345.
  • GRANGER, G.A., SHACK, S.J., WILLIAMS, T.W. & KOLB, W.P. (1969). Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature, 221, 11551157.
  • GRELL, M., BECKE, F.M., WAJANT, H., MANNEL, D.N. & SCHEURICH, P. (1998a). TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. Eur. J. Immunol., 28, 257263.
  • GRELL, M., DOUNI, E., WAJANT, H., LOHDEN, M., CLAUSS, M., MAXEINER, B., GEORGOPOULOS, S., LESSLAUER, W., KOLLIAS, G., PFIZENMAIER, K. & SCHEURICH, P. (1995). The transmembrane form of tumor-necrosis-factor is the prime activating ligand of the 80 kDa tumor-necrosis-factor receptor. Cell, 83, 793802.
  • GRELL, M., SCHEURICH, P., MEAGER, A. & PFIZENMAIER, K. (1993). TR60 and TR80 tumor-necrosis-factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res., 12, 143148.
  • GRELL, M., WAJANT, H., ZIMMERMANN, G. & SCHEURICH, P. (1998b). The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc. Natl. Acad. Sci. U.S.A., 95, 570575.
  • GRELL, M., ZIMMERMANN, G., GOTTFRIED, E., CHEN, C.M., GRUNWALD, U., HUANG, D.C.S., LEE, Y.H.W., DURKOP, H., ENGELMANN, H., SCHEURICH, P., WAJANT, H. & STRASSER, A. (1999). Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J., 18, 30343043.
  • GRELL, M., ZIMMERMANN, G., HULSER, D., PFIZENMAIER, K. & SCHEURICH, P. (1994). TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J. Immunol., 153, 19631972.
  • GU, C.H., CASTELLINO, A., CHAN, J.Y.H. & CHAO, M.V. (1998). BRE: a modulator of TNF-α action. FASEB J., 12, 11011108.
  • GUO, D.Q., WU, L.W., DUNBAR, J.D., OZES, O.N., MAYO, L.D., KESSLER, K.M., GUSTIN, J.A., BAERWALD, M.R., JAFFE, E.A., WARREN, R.S. & DONNER, D.B. (2000). Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation. J. Biol. Chem., 275, 1121611221.
  • HAAS, E., GRELL, M., WAJANT, H. & SCHEURICH, P. (1999). Continuous autotropic signaling by membrane-expressed tumor necrosis factor. J. Biol. Chem., 274, 1810718112.
  • HAN, Y.Q., WEINMAN, S., BOLDOGH, I., WALKER, R.K. & BRASIER, A.R. (1999). Tumor necrosis factor-α-inducible IκBα proteolysis mediated by cytosolic m-calpain – a mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-κB activation. J. Biol. Chem., 274, 787794.
  • HANNUN, Y.A. (1994). The sphinogomyelin cycle and the second messenger function of ceramide. J. Biol. Chem., 269, 31253128.
  • HARIDAS, V., DARNAY, B.G., NATARAJAN, K., HELLER, R. & AGGARWAL, B.B. (1998). Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-κB activation, and c-Jun kinase activation. J. Immunol., 160, 31523162.
  • HAYAKAWA, M., ISHIDA, N., TAKEUCHI, K., SHIBAMOTO, S., HORI, T., OKU, N., ITO, F. & TSUJIMOTO, M. (1993). Arachidonic acid-selective cytosolic phospholipase-A2 is crucial in the cytotoxic action of tumor-necrosis-factor. J. Biol. Chem., 268, 1129011295.
  • HELLER, R.A., SONG, K., FAN, N. & CHANG, D.J. (1992). The p70 tumor-necrosis-factor receptor mediates cytotoxicity. Cell, 70, 4756.
  • HELMS, M.J., MOHAMED, A.A.A. & MACEWAN, D.J. (2001). Modulated kinase activities in cells undergoing tumour necrosis factor-induced apoptotic cell death. FEBS Lett., 505, 6874.
  • HERNANDEZMUNOZ, I., DELATORRE, P., SANCHEZALCAZAR, J.A., GARCIA, I., SANTIAGO, E., MUNOZYAGUE, M. & SOLISHERRUZO, J.A. (1997). Tumor necrosis factor α inhibits collagen α1i gene expression in rat hepatic stellate cells through a g protein. Gastroenterol., 113, 625640.
  • HIGUCHI, M. & AGGARWAL, B.B. (1994). TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J. Immunol., 152, 35503558.
  • HILDT, E. & OESS, S. (1999). Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor 1. J. Exp. Med., 189, 17071714.
  • HOECK, W.G., RAMESHA, C.S., CHANG, D.J., FAN, N. & HELLER, R.A. (1993). Cytoplasmic phospholipase-A2 activity and gene-expression are stimulated by tumor-necrosis-factor – dexamethasone blocks the induced synthesis. Proc. Natl. Acad. Sci. U.S.A., 90, 44754479.
  • HOHMANN, H.P., BROCKHAUS, M., BAEUERLE, P.A., REMY, R., KOLBECK, R. & VAN LOON, A.P. (1990). Expression of the types a and b tumour necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-κB. TNF α is not needed for induction of a biological effect via TNF receptors. J. Biol. Chem., 265, 2240922417.
  • HOLLER, N., ZARU, R., MICHEAU, O., THOME, M., ATTINGER, A., VALITUTTI, S., BODMER, J.L., SCHNEIDER, P., SEED, B. & TSCHOPP, J. (2000). Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunol., 1, 489495.
  • HOROWITZ, M.C., XI, Y.G., WILSON, K. & KACENA, M.A. (2001). Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev., 12, 918.
  • HOTAMISLIGIL, G.S., MURRAY, D.L., CHOY, L.N. & SPIEGELMAN, B.M. (1994). Tumor-necrosis-factor-α inhibits signaling from the insulin-receptor. Proc. Natl. Acad. Sci. U.S.A., 91, 48544858.
  • HOTAMISLIGIL, G.S., SHARGILL, N.S. & SPIEGELMAN, B.M. (1993). Adipose expression of tumor-necrosis-factor-α-direct role in obesity-linked insulin resistance. Science, 259, 8791.
  • HSU, H.L., HUANG, J.N., SHU, H.B., BAICHWAL, V. & GOEDDEL, D.V. (1996a). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity, 4, 387396.
  • HSU, H.L., SHU, H.B., PAN, M.G. & GOEDDEL, D.V. (1996b). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84, 299308.
  • HSU, H.L., XIONG, J. & GOEDDEL, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell-death and NF-κ-B activation. Cell, 81, 495504.
  • HUGHES, A.E., RALSTON, S.H., MARKEN, J., BELL, C., MACPHERSON, H., WALLACE, R.G.H., VAN HUL, W., WHYTE, M.P., NAKATSUKA, K., HOVY, L. & ANDERSON, D.M. (2000). Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nature Genet., 24, 4548.
  • HUNTER, I., COBBAN, H.J., MACEWAN, D.J. & NIXON, G.F. (2001). Tumour necrosis factor-α increases the Ca2+ sensitivity of myosin light chain20 phosphorylation in cultured airway smooth muscle cells via a rho-activated pathway. FASEB J., 15, A163.
  • IDRISS, H.T. & NAISMITH, J.H. (2000). TNF α and the TNF receptor superfamily: structure-function relationship(s). Microsc. Res. Tech., 50, 184195.
  • INOUE, J., ISHIDA, T., TSUKAMOTO, N., KOBAYASHI, N., NAITO, A., AZUMA, S. & YAMAMOTO, T. (2000). Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res., 254, 1424.
  • IRMLER, M., THOME, M., HAHNE, M., SCHNEIDER, P., HOFMANN, B., STEINER, V., BODMER, J.L., SCHROTER, M., BURNS, K., MATTMANN, C., RIMOLDI, D., FRENCH, L.E. & TSCHOPP, J. (1997). Inhibition of death receptor signals by cellular FLIP. Nature, 388, 190195.
  • JACOBS, M., BROWN, N., ALLIE, N., CHETTY, K. & RYFFEL, B. (2000). Tumor necrosis factor receptor 2 plays a minor role for mycobacterial immunity. Pathobiology, 68, 6875.
  • JAYADEV, S., HAYTER, H.L., ANDRIEU, N., GAMARD, C.J., LIU, B., BALU, R., HAYAKAWA, M., ITO, F. & HANNUN, Y.A. (1997). Phospholipase A2 is necessary for tumor necrosis factor α-induced ceramide generation in L929 cells. J. Biol. Chem., 272, 1719617203.
  • JIANG, Y.P., WORONICZ, J.D., LIU, W. & GOEDDEL, D.V. (1999). Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science, 283, 543546.
  • JIN, D.Y., TERAMOTO, H., GIAM, C.Z., CHUN, R.F., GUTKIND, J.S. & JEANG, K.T. (1997). A human suppressor of c-Jun N-terminal kinase 1 activation by tumor necrosis factor α. J. Biol. Chem., 272, 2581625823.
  • JOHANNES, F.J., HORN, J., LINK, G., HAAS, E., SIEMIENSKI, K., WAJANT, H. & PFIZENMAIER, K. (1998). Protein kinase C μ downregulation of tumor-necrosis-factor-induced apoptosis correlates with enhanced expression of nuclear-factor-κB-dependent protective genes. Eur. J. Biochem., 257, 4754.
  • JOHNSON, D.E. (2000). Noncaspase proteases in apoptosis. Leukemia, 14, 16951703.
  • JONES, S.J., LEDGERWOOD, E.C., PRINS, J.B., GALBRAITH, J., JOHNSON, D.R., POBER, J.S. & BRADLEY, J.R. (1999). TNF recruits TRADD to the plasma membrane but not the trans-golgi network, the principal subcellular location of TNF-R1. J. Immunol., 162, 10421048.
  • JUPP, O.J., MCFARLANE, S.M., ANDERSON, H.M., LITTLEJOHN, A.F., MCKAY, R.H., VANDENABEELE, P. & MACEWAN, D.J. (2001). Type II tumor necrosis factor-α receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38MAPK pathways. Biochem. J., 359, 525535.
  • KALB, A., BLUETHMANN, H., MOORE, M.W. & LESSLAUER, W. (1996). Tumor necrosis factor receptors (TNFR) in mouse fibroblasts deficient in TNFR1 or TNFR2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics. J. Biol. Chem., 271, 2809728104.
  • KANG, J.H., SHIN, I. & HAN, J.S. (1998). Changes of phospholipase d activity in TNF-α and anti- Fas/apo1 monoclonal antibody induced apoptosis in HL-60 and A20 cells. Exp. Mol. Med., 30, 2127.
  • KASSIOTIS, G. & KOLLIAS, G. (2001). Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med., 193, 427434.
  • KATAOKA, T., BUDD, R.C., HOLLER, N., THOME, M., MARTINON, F., IRMLER, M., BURNS, K., HAHNE, M., KENNEDY, N., KOVACSOVICS, M. & TSCHOPP, J. (2000). The caspase-8 inhibitor FLIP promotes activation of NF-κB and ERK signaling pathways. Curr. Biol., 10, 640648.
  • KELLIHER, M.A., GRIMM, S., ISHIDA, Y., KUO, F., STANGER, B.Z. & LEDER, P. (1998). The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity, 8, 297303.
  • KILPATRICK, L.E., SONG, Y.H., ROSSI, M.W. & KORCHAK, H.M. (2000). Serine phosphorylation of p60 tumor necrosis factor receptor by PKC-δ in TNF-α-activated neutrophils. Am. J. Physiol.-Cell Physiol., 279, C2011C2018.
  • KIM, B.C., LEE, M.N., KIM, J.Y., LEE, S.S., CHANG, J.D., KIM, S.S., LEE, S.Y. & KIM, J.H. (1999). Roles of phosphatidylinositol 3-kinase and rac in the nuclear signaling by tumor necrosis factor-α in rat-2 fibroblasts. J. Biol. Chem., 274, 2437224377.
  • KIM, M.Y., LINARDIC, C., OBEID, L. & HANNUN, Y. (1991). Identification of sphingomyelin turnover as an effector mechanism for the action of tumor-necrosis-factor-α and γ-interferon – specific role in cell-differentiation. J. Biol. Chem., 266, 484489.
  • KIM, N., ODGREN, P.R., KIM, D.K., MARKS, S.C. & CHOI, Y.W. (2000). Diverse roles of the tumor necrosis factor family member trance in skeletal physiology revealed by trance deficiency and partial rescue by a lymphocyte-expressed trance transgene. Proc. Natl. Acad. Sci. U.S.A., 97, 1090510910.
  • KINLOCH, R.A., TREHERNE, M., FURNESS, M. & HAJIMOHAMADREZA, I. (1999). The pharmacology of apoptosis. Trends Pharmacol. Sci., 20, 3542.
  • KOLESNICK, R.N. & KRONKE, M. (1998). Regulation of ceramide production and apoptosis. Ann. Rev. Physiol., 60, 643665.
  • KOLLIAS, G., DOUNI, E., KASSIOTIS, G. & KONTOYIANNIS, D. (1999). The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann. Rheum. Dis., 58, 3239.
  • KONG, S.K., FUNG, K.P., CHOY, Y.M. & LEE, C.Y. (1997). Slow increase in intranuclear and cytosolic free calcium concentrations in L929 cells is important in tumour necrosis factor- α-mediated cell death. Oncology, 54, 5562.
  • KONG, Y.Y., FEIGE, U., SAROSI, I., BOLON, B., TAFURI, A., MORONY, S., CAPPARELLI, C., LI, J., ELLIOTT, R., MCCABE, S., WONG, T., CAMPAGNUOLO, G., MORAN, E., BOGOCH, E.R., VAN, G., NGUYEN, L.T., OHASHI, P.S., LACEY, D.L., FISH, E., BOYLE, W.J. & PENNINGER, J.M. (1999). Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature, 402, 304309.
  • KONTOYIANNIS, D. & KOLLIAS, G. (2000). Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur. J. Immunol., 30, 20382047.
  • KRAMER, R.M., ROBERTS, E.F., UM, S.L., BORSCHHAUBOLD, A.G., WATSON, S.P., FISHER, M.J. & JAKUBOWSKI, J.A. (1996). p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets-evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J. Biol. Chem., 271, 2772327729.
  • KRUPPA, G., THOMA, B., MACHLEIDT, T., WIEGMANN, K. & KRONKE, M. (1992). Inhibition of tumor-necrosis-factor (TNF)-mediated NF-κ-B activation by selective blockade of the human 55-kDa TNF receptor. J. Immunol., 148, 31523157.
  • KUIDA, K., HAYDAR, T.F., KUAN, C.Y., GU, Y., TAYA, C., KARASUYAMA, H., SU, M.S.S., RAKIC, P. & FLAVELL, R.A. (1998). Reduced apoptosis and cytochrome C-mediated caspase activation in mice lacking caspase 9. Cell, 94, 325337.
  • KUIDA, K., LIPPKE, J.A., KU, G., HARDING, M.W., LIVINGSTON, D.J., SU, M.S.S. & FLAVELL, R.A. (1995). Altered cytokine export and apoptosis in mice deficient in interleukin-1-β converting-enzyme. Science, 267, 20002003.
  • KUIDA, K., ZHENG, T.S., NA, S.Q., KUAN, C.Y., YANG, D., KARASUYAMA, H., RAKIC, P. & FLAVELL, R.A. (1996). Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature, 384, 368372.
  • KUJIME, K., HASHIMOTO, S., GIN, Y., SHIMIZU, K. & HORIE, T. (2000). p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase regulate rantes production by influenza virus-infected human bronchial epithelial cells. J. Immunol., 164, 32223228.
  • KULL, F.C., JACOBS, S. & CUATRECASAS, P. (1985). Cellular receptor for i-125-labeled tumor necrosis factor-specific binding, affinity labeling, and relationship to sensitivity. Proc. Natl. Acad. Sci. U.S.A., 82, 57565760.
  • KUSTERS, S., TIEGS, G., ALEXOPOULOU, L., PASPARAKIS, M., DOUNI, E., KUNSTLE, G., BLUETHMANN, H., WENDEL, A., PFIZENMAIER, K., KOLLIAS, G. & GRELL, M. (1997). In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol., 27, 28702875.
  • LAEGREID, A., MEDVEDEV, A., NONSTAD, U., BOMBARA, M.P., RANGES, G., SUNDAN, A. & ESPEVIK, T. (1994). Tumor-necrosis-factor receptor p75 mediates cell-specific activation of nuclear factor κ-B and induction of human cytomegalovirus enhancer. J. Biol. Chem., 269, 77857791.
  • LAOUAR, A., GLESNE, D. & HUBERMAN, E. (1999). Involvement of protein kinase C-β and ceramide in tumor necrosis factor-α-induced but not Fas-induced apoptosis of human myeloid leukemia cells. J. Biol. Chem., 274, 2352623534.
  • LAZDINS, J.K., GRELL, M., WALKER, M.R., WOODSCOOK, K., SCHEURICH, P. & PFIZENMAIER, K. (1997). Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells. J. Exp. Med., 185, 8190.
  • LEDGERWOOD, E.C., POBER, J.S. & BRADLEY, J.R. (1999). Recent advances in the molecular basis of TNF signal transduction. Lab. Invest., 79, 10411050.
  • LEE, J.I. & BURCKART, G.J. (1998). Nuclear factor κB: important transcription factor and therapeutic target. J. Clin. Pharmacol., 38, 981993.
  • LEE, J.Y., HANNUN, Y.A. & OBEID, L.M. (2000). Functional dichotomy of protein kinase C (PKC) in tumor necrosis factor-α (TNF-α) signal transduction in L929 cells-translocation and inactivation of PKC by TNF-α. J. Biol. Chem., 275, 2929029298.
  • LEE, S.Y., REICHLIN, A., SANTANA, A., SOKOL, K.A., NUSSENZWEIG, M.C. & CHOI, Y. (1997). TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity, 7, 703713.
  • LEEUWENBERG, J.F.M., VANTITS, L.J.H., JEUNHOMME, T.M.A.A. & BUURMAN, W.A. (1995). Evidence for exclusive role in signaling of tumor-necrosis-factor p55 receptor and a potentiating function of p75 receptor on human endothelial-cells. Cytokine, 7, 457462.
  • LEWIS, M., TARTAGLIA, L.A., LEE, A., BENNETT, G.L., RICE, G.C., WONG, G.H.W., CHEN, E.Y. & GOEDDEL, D.V. (1991). Cloning and expression of cDNAs for two distinct murine tumor-necrosis- factor receptors demonstrate one receptor is species-specific. Proc. Natl. Acad. Sci. U.S.A., 88, 28302834.
  • LI, J., SAROSI, I., YAN, X.Q., MORONY, S., CAPPARELLI, C., TAN, H.L., MCCABE, S., ELLIOTT, R., SCULLY, S., VAN, G., KAUFMAN, S., JUAN, S.C., SUN, Y., TARPLEY, J., MARTIN, L., CHRISTENSEN, K., MCCABE, J., KOSTENUIK, P., HSU, H., FLETCHER, F., DUNSTAN, C.R., LACEY, D.L. & BOYLE, W.J. (2000). RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U.S.A., 97, 15661571.
  • LIN, L.L., WARTMANN, M., LIN, A.Y., KNOPF, J.L., SETH, A. & DAVIS, R.J. (1993). cPLA2 is phosphorylated and activated by MAP kinase. Cell, 72, 269278.
  • LIN, W.-W. & CHEN, B.C. (1998). Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages. Br. J. Pharmacol., 125, 16011609.
  • LIN, Y., DEVIN, A., RODRIGUEZ, Y. & LIU, Z.G. (1999). Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev., 13, 25142526.
  • LING, L., CAO, Z.D. & GOEDDEL, D.V. (1998). NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. U.S.A., 95, 37923797.
  • LIU, Z.G., HSU, H.L., GOEDDEL, D.V. & KARIN, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell, 87, 565576.
  • LOCKSLEY, R.M., KILLEEN, N. & LENARDO, M.J. (2001). The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell, 104, 487501.
  • LOETSCHER, H., STUEBER, D., BANNER, D., MACKAY, F. & LESSLAUER, W. (1993). Human tumor-necrosis-factor-α (TNF-α) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J. Biol. Chem., 268, 2635026357.
  • LOZANO, J., BERRA, E., MUNICIO, M.M., DIAZMECO, M.T., DOMINGUEZ, I., SANZ, L. & MOSCAT, J. (1994). Protein-kinase-c-ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J. Biol. Chem., 269, 1920019202.
  • LUCAS, R., GARCIA, I., DONATI, Y.R.A., HRIBAR, M., MANDRIOTA, S.J., GIROUD, C., BUURMAN, W.A., FRANSEN, L., SUTER, P.M., NUNEZ, G., PEPPER, M.S. & GRAU, G.E. (1998). Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells. Eur. J. Immunol., 28, 35773586.
  • LUCAS, R., JUILLARD, P., DECOSTER, E., REDARD, M., BURGER, D., DONATI, Y., GIROUD, C., MONSOHINARD, C., DEKESEL, T., BUURMAN, W.A., MOORE, M.W., DAYER, J.M., FIERS, W., BLUETHMANN, H. & GRAU, G.E. (1997a). Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol., 27, 17191725.
  • LUCAS, R., LOU, J.N., JUILLARD, P., MOORE, M., BLUETHMANN, H. & GRAU, G.E. (1997b). Respective role of TNF receptors in the development of experimental cerebral malaria. J. Neuroimmunol., 72, 143148.
  • LUSCHEN, S., USSAT, S., KRONKE, M. & ADAMKLAGES, S. (1998). Cleavage of human cytosolic phospholipase A2 by caspase-1 (ICE) and caspase-8 (FLICE). Biochem. Biophys. Res. Commun., 253, 9298.
  • MACDONALD, T.T., MONTELEONE, G. & PENDER, S.L.F. (2000). Recent developments in the immunology of inflammatory bowel disease. Scand. J. Immunol., 51, 29.
  • MACEWAN, D.J. (1996). Elevated cPLA2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosis. FEBS Lett., 379, 7781.
  • MALININ, N.L., BOLDIN, M.P., KOVALENKO, A.V. & WALLACH, D. (1997). MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature, 385, 540544.
  • MANNA, S.K. & AGGARWAL, B.B. (1998). Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-κB, AP-1, and c-Jun N-terminal kinase-comparison with interleukin-13. J. Biol. Chem., 273, 3333333341.
  • MANNA, S.K. & AGGARWAL, B.B. (1999). Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-κB activation and gene expression. J. Immunol., 162, 20952102.
  • MANNA, S.K., MUKHOPADHYAY, A., VAN, N.T. & AGGARWAL, B.B. (1999). Silymarin suppresses TNF-induced activation of NF-κB, c-Jun N-terminal kinase, and apoptosis. J. Immunol., 163, 68006809.
  • MARONEY, A.C., FINN, J.P., CONNORS, T.J., DURKIN, J.T., ANGELES, T., GESSNER, G., XU, Z.H., MEYER, S.L., SAVAGE, M.J., GREENE, L.A., SCOTT, R.W. & VAUGHT, J.L. (2001). CEP-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J. Biol. Chem., 276, 2530225308.
  • MARQUET, R.L., DEBRUIN, R.W.F., FIERS, W. & JEEKEL, J. (1987). Indomethacin reduces TNF-toxicity without interfering with its efficacy. Immunobiology, 175, 5455.
  • MATHIAS, S., DRESSLER, K.A. & KOLESNICK, R.N. (1991). Characterization of a ceramide-activated protein-kinase-stimulation by tumor-necrosis-factor-α. Proc. Natl. Acad. Sci. U.S.A., 88, 1000910013.
  • MATHIAS, S., PENA, L.A. & KOLESNICK, R.N. (1998). Signal transduction of stress via ceramide. Biochem. J., 335, 465480.
  • MATSUDA, S. & KOYASU, S. (2000). Mechanisms of action of cyclosporine. Immunopharmacology, 47, 119125.
  • MAYER, A.M.S., BRENIC, S. & GLASER, K.B. (1996). Pharmacological targeting of signaling pathways in protein kinase C-stimulated superoxide generation in neutrophil-like HL-60 cells: effect of phorbol ester, arachidonic acid and inhibitors of kinase(s), phosphatase(s) and phospholipase A2. J. Pharmacol. Exp. Ther., 279, 633644.
  • MCDERMOTT, M.F. (2001). TNF and TNFR biology in health and disease. Cell. Mol. Biol., 47, 619635.
  • MCFARLANE, S.M., ANDERSON, H.M., TUCKER, S.J., JUPP, O.J. & MACEWAN, D.J. (2000). Unmodified calcium concentrations in tumour necrosis factor receptor subtype-mediated apoptotic cell death. Mol. Cell. Biochem., 211, 1926.
  • MCFARLANE, S.M., JUPP, O.J., COBBAN, H.J., HUNTER, I., ANDERSON, H.M., VANDENABEELE, P., NIXON, G.F. & MACEWAN, D.J. (2001). Stimulation of stress-activated but not mitogen-activated protein kinases by tumour necrosis factor receptor subtypes in airway smooth muscle. Biochem. Pharmacol., 61, 749759.
  • MCLEISH, K.R., KLEIN, J.B., LEDERER, E.D., HEAD, K.Z. & WARD, R.A. (1996). Azotemia, TNF α, and 1ps prime the human neutrophil oxidative burst by distinct mechanisms. Kidney Int., 50, 407416.
  • MEDVEDEV, A.E., ESPEVIK, T., RANGES, G. & SUNDAN, A. (1996). Distinct roles of the two tumor necrosis factor (TNF) receptors in modulating TNF and lymphotoxin α effects. J. Biol. Chem., 271, 97789784.
  • MIN, W. & POBER, J.S. (1997). TNF initiates e-selectin transcription in human endothelial cells through parallel TRAF-NF-κB and TRAF-rac/cdc42-JNK-c-Jun/ATF2 pathways. J. Immunol., 159, 35083518.
  • MINDEN, A., LIN, A., MCMAHON, M., LANGECARTER, C., DERIJARD, B., DAVIS, R.J., JOHNSON, G.L. & KARIN, M. (1994). Differential activation of ERK and JNK mitogen-activated protein-kinases by raf-1 and MEKK. Science, 266, 17191723.
  • MISHRA, S., MATHUR, R. & HAMBURGER, A.W. (1994). Modulation of the cytotoxic activity of tumor-necrosis-factor by protein-tyrosine kinase and protein-tyrosine-phosphatase inhibitors. Lymphokine Cytokine Res., 13, 7783.
  • MOORE, R.J., OWENS, D.M., STAMP, G., ARNOTT, C., BURKE, F., EAST, N., HOLDSWORTH, H., TURNER, L., ROLLINS, B., PASPARAKIS, M., KOLLIAS, G. & BALKWILL, F. (1999). Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nature Med., 5, 828831.
  • MOOSMAYER, D., DINKEL, A., GERLACH, E., HESSABI, B., GRELL, M., PFIZENMAIER, K. & SCHEURICH, P. (1994). Coexpression of the human TNF receptors tr6o and TR80 in insect cells-analysis of receptor complex-formation. Lymphokine Cytokine Res., 13, 295301.
  • MORINVILLE, A., MAYSINGER, D. & SHAVER, A. (1998). From vanadis to atropos: vanadium compounds as pharmacological tools in cell death signalling. Trends Pharmacol. Sci., 19, 452460.
  • MULLER, G., AYOUB, M., STORZ, P., RENNECKE, J., FABBRO, D. & PFIZENMAIER, K. (1995). PKC ζ is a molecular switch in signal-transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic-acid. EMBO J., 14, 19611969.
  • MULLER, G., STORZ, P., BOURTEELE, S., DOPPLER, H., PFIZENMAIER, K., MISCHAK, H., PHILIPP, A., KAISER, C. & KOLCH, W. (1998). Regulation of raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling. EMBO J., 17, 732742.
  • MURAKATA, C., KANEKO, M., MATSUDA, Y., SAITO, H., SAITO, Y., TANAKA, E., TAMAOKI, T., MATSUMOTO, T., KANER, J.C., HUDKINS, R.L., ROTELLA, D.P., GLICKSMAN, M.A., SAPORITO, M., CARSWELL, S., HAUN, F., KNIGHT, E., DIONNE, C., NEFF, N.T., VAUGHT, J.L. & MALLAMO, J.P. (1996). Neurotrophic derivatives of K252a. profile of CEP1347/KT7515 and SAR of survival promoting analogs. Abstr. Papers Am. Chemical Soc., 212, 211.
  • MUZIO, M., CHINNAIYAN, A.M., KISCHKEL, F.C., O'ROURKE, K., SHEVCHENKO, A., NI, J., SCAFFIDI, C., BRETZ, J.D., ZHANG, M., GRENTZ, R., MANN, M., KRAMMER, P.H., PETER, M.E. & DIXIT, V.M. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/apo-1) death-inducing signaling complex. Cell, 85, 817827.
  • NASUHARA, Y., ADCOCK, I.M., CATLEY, M., BARNES, P.J. & NEWTON, R. (1999). Differential IκB kinase activation and IκBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells-evidence for additional regulatory steps in κB-dependent transcription. J. Biol. Chem., 274, 1996519972.
  • NEMENOFF, R.A., WINITZ, S., QIAN, N.X., VANPUTTEN, V., JOHNSON, G.L. & HEASLEY, L.E. (1993). Phosphorylation and activation of a high-molecular-weight form of phospholipase-A2 by p42 microtubule-associated protein-2 kinase and protein-kinase-C. J. Biol. Chem., 268, 19601964.
  • NISHITOH, H., SAITOH, M., MOCHIDA, Y., TAKEDA, K., NAKANON, H., ROTHE, M., MIYAZONO, K. & ICHIJO, H. (1998). Ask1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell., 2, 120.
  • ODEH, M. (2001). The role of tumour necrosis factor-α in the pathogenes of complicated falciparum malaria. Cytokine, 14, 1118.
  • O'DWYER, M.E. & DRUKER, B.J. (2001). Chronic myelogenous leukaemia – new therapeutic principles. J. Intern. Med., 250, 39.
  • OKAZAKI, T., BELL, R.M. & HANNUN, Y.A. (1989). Sphingomyelin turnover induced by vitamin-D3 in HL-60 cells – role in cell-differentiation. J. Biol. Chem., 264, 1907619080.
  • OLD, L.J. (1985). Tumor necrosis factor (TNF). Science, 230, 630632.
  • OZES, O.N., MAYO, L.D., GUSTIN, J.A., PFEFFER, S.R., PFEFFER, L.M. & DONNER, D.B. (1999). NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature, 401, 8285.
  • PALEOLOG, E.M., DELASALLE, S.A.J., BUURMAN, W.A. & FELDMANN, M. (1994). Functional activities of receptors for tumor-necrosis-factor-α on human vascular endothelial-cells. Blood, 84, 25782590.
  • PARRIS, J.R.M., COBBAN, H.J., LITTLEJOHN, A.F., MACEWAN, D.J. & NIXON, G.F. (1999). Tumour necrosis factor-α activates a calcium sensitization pathway in guinea-pig bronchial smooth muscle. J. Physiol., 518, 561569.
  • PAUL, A., WILSON, S., BELHAM, C.M., ROBINSON, C.J.M., SCOTT, P.H., GOULD, G.W. & PLEVIN, R. (1997). Stress-activated protein kinases: activation, regulation and function. Cell. Signal., 9, 403410.
  • PENNICA, D., KOHR, W.J., FENDLY, B.M., SHIRE, S.J., RAAB, H.E., BORCHARDT, P.E., LEWIS, M. & GOEDDEL, D.V. (1992a). Characterization of a recombinant extracellular domain of the type-1 tumor-necrosis-factor receptor – evidence for tumor-necrosis-factor-α induced receptor aggregation. Biochemistry, 31, 11341141.
  • PENNICA, D., LAM, V.T., MIZE, N.K., WEBER, R.F., LEWIS, M., FENDLY, B.M., LIPARI, M.T. & GOEDDEL, D.V. (1992b). Biochemical-properties of the 75-kDa tumor-necrosis-factor receptor – characterization of ligand-binding, internalization, and receptor phosphorylation. J. Biol. Chem., 267, 2117221178.
  • PERONA, R., MONTANER, S., SANIGER, L., SANCHEZPEREZ, I., BRAVO, R. & LACAL, J.C. (1997). Activation of the nuclear factor-κB by rho, cdc42, and rac-1 proteins. Genes Dev., 11, 463475.
  • PETRACHE, I., VERIN, A.D., CROW, M.T., BIRUKOVA, A., LIU, F. & GARCIA, J.G.N. (2001). Differential effect of MLC kinase in TNF-α-induced endothelial cell apoptosis and barrier dysfunction. Am. J. Physiol.-Lung Cell. Mol. Physiol., 280, L1168L1178.
  • PFEFFER, K., MATSUYAMA, T., KUNDIG, T.M., WAKEHAM, A., KISHIHARA, K., SHAHINIAN, A., WIEGMANN, K., OHASHI, P.S., KRONKE, M. & MAK, T.W. (1993). Mice deficient for the 55 kDa tumor-necrosis-factor receptor are resistant to endotoxic-shock, yet succumb to L-monocytogenes infection. Cell, 73, 457467.
  • PIMENTEL-MUINOS, F.X. & SEED, B. (1999). Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity, 11, 783793.
  • POLLOCK, J., MCFARLANE, S.M., CONNELL, M.C., ZEHAVI, U., VANDENABEELE, P., MACEWAN, D.J. & SCOTT, R.H. (2002). TNF receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones. Neuropharmacology, 42, 93106.
  • POLLOCK, V.P., LOFTHOUSE, E.J., JUPP, O.J., GAULD, S.B., ANDERSON, H.M. & MACEWAN, D.J. (2000). Selective down-regulation of the Gqα/G11α G-protein family in tumour necrosis factor-α induced cell death. Mol. Cell. Biochem., 206, 6774.
  • PORNARES, M.I., ARES, M.P.S. & ORRENIUS, S. (1998a). Calcium signalling and the regulation of apoptosis. Toxicol. in vitro, 12, 539543.
  • PORNARES, M.I., SAMALI, A. & ORRENIUS, S. (1998b). Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Diff., 5, 10281033.
  • PORTEU, F. & HIEBLOT, C. (1994). Tumor-necrosis-factor induces a selective shedding of its p75-receptor from human neutrophils. J. Biol. Chem., 269, 28342840.
  • PROBERT, L., EUGSTER, H.P., AKASSOGLOU, K., BAUER, J., FREI, K., LASSMANN, H. & FONTANA, A. (2000). TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain, 123, 20052019.
  • PULS, A., ELIOPOULOS, A.G., NOBES, C.D., BRIDGES, T., YOUNG, L.S. & HALL, A. (1999). Activation of the small GTPase cdc42 by the inflammatory cytokines TNF α and IL-1, and by the epstein-barr virus transforming protein lmp 1. J. Cell Sci., 112, 29832992.
  • PYNE, S. & PYNE, N.J. (2000). Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J., 349, 385402.
  • RAINES, M.A., KOLESNICK, R.N. & GOLDE, D.W. (1993). Sphingomyelinase and ceramide activate mitogen-activated protein-kinase in myelin HL-60 cells. J. Biol. Chem., 268, 1457214575.
  • RAO, K.M.K. (2001). MAP kinase activation in macrophages. J. Leukoc. Biol., 69, 310.
  • RAVICHANDRAN, L.V., ESPOSITO, D.L., CHEN, J. & QUON, M.J. (2001). Protein kinase C-ζ phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J. Biol. Chem., 276, 35433549.
  • REITHMANN, C. & WERDAN, K. (1994). Tumor-necrosis-factor-α decreases inositol phosphate formation and phosphatidylinositol-bisphosphate (PIP2) synthesis in rat cardiomyocytes. Naunyn Schmiedebergs Arch. Pharmacol., 349, 175182.
  • REYES, J.G., ROBAYNA, I.G., DELGADO, P.S., GONZALEZ, I.H., AGUIAR, J.Q., ROSAS, F.E., FANJUL, L.F. & DEGALARRETA, C.M.R. (1996). c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells. J. Biol. Chem., 271, 2137521380.
  • RICH, T., ALLEN, R.L. & WYLLIE, A.H. (2000). Defying death after DNA damage. Nature, 407, 777783.
  • ROSADO, J.A., ROSENZWEIG, I., HARDING, S. & SAGE, S.O. (2001). Tumor necrosis factor-α inhibits store-mediated Ca2+ entry in the human hepatocellular carcinoma cell line HEPG2. Am. J. Physiol.-Cell Physiol., 280, C1636C1644.
  • ROTHE, J., LESSLAUER, W., LOTSCHER, H., LANG, Y., KOEBEL, P., KONTGEN, F., ALTHAGE, A., ZINKERNAGEL, R., STEINMETZ, M. & BLUETHMANN, H. (1993). Mice lacking the tumor-necrosis-factor receptor-1 are resistant to TNF-mediated toxicity but highly susceptible to infection by listeria-monocytogenes. Nature, 364, 798802.
  • ROTHE, M., PAN, M.G., HENZEL, W.J., AYRES, T.M. & GOEDDEL, D.V. (1995a). The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral-inhibitor of apoptosis proteins. Cell, 83, 12431252.
  • ROTHE, M., SARMA, V., DIXIT, V.W. & GOEDDEL, D.V. (1995b). TRAF2-mediated activation of NF-κ-B by TNF receptor-2 and CD40. Science, 269, 14241427.
  • ROTHE, M., WONG, S.C., HENZEL, W.J. & GOEDDEL, D.V. (1994). A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor-necrosis-factor receptor. Cell, 78, 681692.
  • SALTIEL, A.R. (2001). New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell, 104, 517529.
  • SANZ, L., SANCHEZ, P., LALLENA, M.J., DIAZ-MECO, M.T. & MOSCAT, J. (1999). The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J., 18, 30443053.
  • SAWAI, H., OKAZAKI, T., TAKEDA, Y., TASHIMA, M., SAWADA, H., OKUMA, M., KISHI, S., UMEHARA, H. & DOMAE, N. (1997). Ceramide-induced translocation of protein kinase C-δ and -ε to the cytosol – implications in apoptosis. J. Biol. Chem., 272, 24522458.
  • SCHALL, T.J., LEWIS, M., KOLLER, K.J., LEE, A., RICE, G.C., WONG, G.H.W., GATANAGA, T., GRANGER, G.A., LENTZ, R., RAAB, H., KOHR, W.J. & GOEDDEL, D.V. (1990). Molecular-cloning and expression of a receptor for human tumor-necrosis-factor. Cell, 61, 361370.
  • SCHEID, M. & DURONIO, V. (1998). Dissociation of cytokine-induced phosphorylation of bad and activation of PKB/Akt: involvement of MEK upstream of bad phosphorylation. Proc. Natl. Acad. Sci., 95, 74397444.
  • SCHERZER, J.A., LIN, Y., MCLEISH, K.R. & KLEIN, J.B. (1997). TNF translationally modulates the expression of G protein αi2 subunits in human polymorphonuclear leukocytes. J. Immunol., 158, 913918.
  • SCHIEVELLA, A.R., CHEN, J.H., GRAHAM, J.R. & LIN, L.-L. (1997). MADD, a novel death domain protein that interacts with the type 1 tumour necrosis factor receptor and activates mitogen-activated protein kinase. J. Biol. Chem., 272, 1206912075.
  • SCHLUTER, D. & DECKERT, M. (2000). The divergent role of tumor necrosis factor receptors in infectious diseases. Microbes Inf., 2, 12851292.
  • SCHOTTE, P., DECLERCQ, W., VANHUFFEL, S., VANDENABEELE, P. & BEYAERT, R. (1999). Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett., 442, 117121.
  • SCHUBERT, K.M., SCHEID, M.P. & DURONIO, V. (2000). Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J. Biol. Chem., 275, 1333013335.
  • SCHUTZE, S., BERKOVIC, D., TOMSING, O., UNGER, C. & KRONKE, M. (1991). Tumor necrosis factor induces rapid production of 1′2′diacylglycerol by a phosphatidylcholine-specific phospholipase C. J. Exp. Med., 174, 975988.
  • SCHUTZE, S., NOTTROTT, S., PFIZENMAIER, K. & KRONKE, M. (1990). Tumor-necrosis-factor signal transduction – cell-type-specific activation and translocation of protein kinase-C. J. Immunol., 144, 26042608.
  • SCHWENGER, P., ALPERT, D., SKOLNIK, E.Y. & VILCEK, J. (1998). Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IκBα phosphorylation and degradation. Mol. Cell. Biol., 18, 7884.
  • SCREATON, G. & XU, X.N. (2000). T cell life and death signalling via TNF-Receptor family members. Curr. Opin. Immunol., 12, 316322.
  • SETHI, J.K., XU, H.Y., UYSAL, T., WIESBROCK, S.M., SCHEJA, L. & HOTAMISLIGIL, G.S. (2000). Characterisation of receptor-specific TNF α functions in adipocyte cell lines lacking type 1 and 2 TNF receptors. FEBS Lett., 469, 7782.
  • SHI, C.S. & KEHRL, J.H. (1997). Activation of stress-activated protein kinase c-Jun N-terminal kinase, but not NF-κB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway. J. Biol. Chem., 272, 3210232107.
  • SINGH, S. & AGGARWAL, B.B. (1995). Protein-tyrosine-phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-κ-B. J. Biol. Chem., 270, 1063110639.
  • SONG, H.Y., ROTHE, M. & GOEDDEL, D.V. (1996). The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl. Acad. Sci. U.S.A., 93, 67216725.
  • SPEISER, D.E., BACHMANN, M.F., FRICK, T.W., MCKALLFAIENZA, K., GRIFFITHS, E., PFEFFER, K., MAK, T.W. & OHASHI, P.S. (1997). TNF receptor p55 controls early acute graft-versus-host disease. J. Immunol., 158, 51855190.
  • SQUIER, M.K.T. & COHEN, J.J. (1996). Calpain and cell death. Cell Death Diff., 3, 275283.
  • STANGER, B.Z., LEDER, P., LEE, T.H., KIM, E. & SEED, B. (1995). RIP – a novel protein containing a death domain that interacts with Fas/Apo-1 (CD95) in yeast and causes cell-death. Cell, 81, 513523.
  • STORZ, P., DOPPLER, H., WERNIG, A., PFIZENMAIER, K. & MULLER, G. (1998). TNF inhibits insulin induced STAT5 activation in differentiated mouse muscle cells PMI28. FEBS Lett., 440, 4145.
  • SUFFYS, P., BEYAERT, R., DEVALCK, D., VANHAESEBROECK, B., VANROY, F. & FIERS, W. (1991). Tumor-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic-acid release per- se. Eur. J. Biochem., 195, 465475.
  • TARTAGLIA, L.A., AYRES, T.M., WONG, G.H.W. & GOEDDEL, D.V. (1993a). A novel domain within the 55 kDa TNF receptor signals cell-death. Cell, 74, 845853.
  • TARTAGLIA, L.A., PENNICA, D. & GOEDDEL, D.V. (1993b). Ligand passing – the 75-kDa tumor-necrosis-factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem., 268, 1854218548.
  • TARTAGLIA, L.A., WEBER, R.F., FIGARI, I.S., REYNOLDS, C., PALLADINO, M.A. & GOEDDEL, D.V. (1991). The two different receptors for tumor-necrosis-factor mediate distinct cellular-responses. Proc. Natl. Acad. Sci. U.S.A., 88, 92929296.
  • TAYLOR, P.C. (2001). Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases. Mol. Biotech., 19, 153168.
  • TEWARI, M., QUAN, L.T., OROURKE, K., DESNOYERS, S., ZENG, Z., BEIDLER, D.R., POIRIER, G.G., SALVESEN, G.S. & DIXIT, V.M. (1995). YAMA/CPP32-β, a mammalian homolog of CED-3, is a CrmA – inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81, 801809.
  • THOMAS, P.S. (2001). Tumour necrosis factor-α: the role of this multifunctional cytokine in asthma. Immunol. Cell Biol., 79, 132140.
    Direct Link:
  • THOME, M., SCHNEIDER, P., HOFMANN, K., FICKENSCHER, H., MEINL, E., NEIPEL, F., MATTMANN, C., BURNS, K., BODMER, J.L., SCHROTER, M., SCAFFIDI, C., KRAMMER, P.H., PETER, M.E. & TSCHOPP, J. (1997). Viral FLICE-inhibitory proteins (FLIPS) prevent apoptosis induced by death receptors. Nature, 386, 517521.
  • TOLAN, D., CONWAY, A.M., STEELE, L., PYNE, S. & PYNE, N.J. (1996). The identification of DL-threo dihydrosphingosine and sphingosine as novel inhibitors of extracellular signal- regulated kinase signalling in airway smooth muscle. Br. J. Pharmacol., 119, 185186.
  • TOTPAL, K., AGARWAL, S. & AGGARWAL, B.B. (1992). Phosphatase inhibitors modulate the growth-regulatory effects of human tumor-necrosis-factor on tumor and normal-cells. Cancer Res., 52, 25572562.
  • TRENT, J.C., MCCONKEY, D.J., LOUGHLIN, S.M., HARBISON, M.T., FERNANDEZ, A. & ANANTHASWAMY, H.N. (1996). Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J., 15, 44974505.
  • TSUJIMOTO, M., YIP, Y.K. & VILCEK, J. (1985). Tumor necrosis factor – specific binding and internalization in sensitive and resistant cells. Proc. Natl. Acad. Sci. U.S.A., 82, 76267630.
  • UTZ, P.J. & ANDERSON, P. (2000). Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules. Cell Death Diff., 7, 589602.
  • UYSAL, K.T., WIESBROCK, S.M., MARINO, M.W. & HOTAMISLIGIL, G.S. (1997). Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature, 389, 610614.
  • VAN ASSCHE, G. & RUTGEERTS, P. (2000). Anti-TNF agents in Crohn's disease. Expert Opin. Investigational Drugs, 9, 103111.
  • VANDENABEELE, P., DECLERCQ, W., BEYAERT, R. & FIERS, W. (1995). 2 Tumor-necrosis-factor receptors – structure and function. Trends Cell Biol., 5, 392399.
  • VANDENBERGHE, W., PLAISANCE, S., BOONE, E., DEBOSSCHER, K., SCHMITZ, M.L., FIERS, W. & HAEGEMAN, G. (1998). p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor κB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem., 273, 32853290.
  • VAN DER VEEN, A.H., TEN HAGEN, T.L.M., DE WILT, J.H.W., VAN IJKEN, M.G.A. & EGGERMONT, A.M.M. (2000). An overview on the use of TNF-α: our experience with regional administration and developments towards new opportunities for systemic application. Anticancer Res., 20, 34673474.
  • VANHAESEBROECK, B. & ALESSI, D.R. (2000). The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J., 346, 561576.
  • VANLINT, J., AGOSTINIS, P., VANDEVOORDE, V., HAEGEMAN, G., FIERS, W., MERLEVEDE, W. & VANDENHEEDE, J.R. (1992). Tumor-necrosis-factor stimulates multiple serine threonine protein-kinases in swiss 3T3 and L929 cells – implication of casein kinase-2 and extracellular signal-regulated kinases in the tumor-necrosis-factor signal transduction pathway. J. Biol. Chem., 267, 2591625921.
  • VANOSTADE, X., VANDENABEELE, P., EVERAERDT, B., LOETSCHER, H., GENTZ, R., BROCKHAUS, M., LESSLAUER, W., TAVERNIER, J., BROUCKAERT, P. & FIERS, W. (1993). Human TNF mutants with selective activity on the p55 receptor. Nature, 361, 266269.
  • VERCAMMEN, D., BEYAERT, R., DENECKER, G., GOOSSENS, V., VANLOO, G., DECLERCQ, W., GROOTEN, J., FIERS, W. & VANDENABEELE, P. (1998a). Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med., 187, 14771485.
  • VERCAMMEN, D., BROUCKAERT, G., DENECKER, G., VANDECRAEN, M., DECLERCQ, W., FIERS, W. & VANDENABEELE, P. (1998b). Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med., 188, 919930.
  • VERCAMMEN, D., VANDENABEELE, P., DECLERCQ, W., VANDECRAEN, M., GROOTEN, J. & FIERS, W. (1995). Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumor-necrosis-factor (TNF) receptor is mediated by endogenous murine TNF. Cytokine, 7, 463470.
  • VERHEIJ, M., BOSE, R., LIN, X.H., YAO, B., JARVIS, W.D., GRANT, S., BIRRER, M.J., SZABO, E., ZON, L.I., KYRIAKIS, J.M., HAIMOVITZFRIEDMAN, A., FUKS, Z. & KOLESNICK, R.N. (1996). Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature, 380, 7579.
  • VILLA, P., KAUFMANN, S.H. & EARNSHAW, W.C. (1997). Caspases and caspase inhibitors. Trends Biochem. Sci., 22, 388393.
  • VOELKELJOHNSON, C., ENTINGH, A.J., WOLD, W.S.M., GOODING, L.R. & LASTER, S.M. (1995). Activation of intracellular proteases is an early event in TNF-induced apoptosis. J. Immunol., 154, 17071716.
  • WAAGE, A., ESPEVIK, T., BAKKE, O., HALSTENSEN, A., BRANDTZAEG, P., NISSENMEYER, J. & LAMVIK, J. (1987). Detection of TNF in human septicemia. Immunobiology, 175, 41.
  • WAJANT, H., HAAS, E., SCHWENZER, R., MUHLENBECK, F., KREUZ, S., SCHUBERT, G., GRELL, M., SMITH, C. & SCHEURICH, P. (2000). Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J. Biol. Chem., 275, 2435724366.
  • WAJANT, H., HENKLER, F. & SCHEURICH, P. (2001). The TNF-Receptor-associated factor family – scaffold molecules for cytokine receptors, kinases and their regulators. Cell. Signal., 13, 389400.
  • WANG, B., KONDO, S., SHIVJI, G.M., FUJISAWA, H., MAK, T.W. & SAUDER, D.N. (1996). Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells. Immunology, 88, 284288.
  • WARD, C., DRANSFIELD, I., CHILVERS, E.R., HASLETT, C. & ROSSI, A.G. (1999). Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol. Sci., 20, 503509.
  • WAY, K.J., CHOU, E. & KING, G.L. (2000). Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci., 21, 181187.
  • WEISS, T., GRELL, M., HESSABI, B., BOURTEELE, S., MULLER, G., SCHEURICH, P. & WAJANT, H. (1997). Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80 – requirement of the TNF receptor-associated factor-2 binding site. J. Immunol., 158, 23982404.
  • WEISS, T., GRELL, M., SIEMIENSKI, K., MUHLENBECK, F., DURKOP, H., PFIZENMAIER, K., SCHEURICH, P. & WAJANT, H. (1998). TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J. Immunol., 161, 31363142.
  • WIDMANN, C., GIBSON, S. & JOHNSON, G.L. (1998). Caspase-dependent cleavage of signaling proteins during apoptosis – a turn-off mechanism for anti-apoptotic signals. J. Biol. Chem., 273, 71417147.
  • WIEGMANN, K., SCHUTZE, S., KAMPEN, E., HIMMLER, A., MACHLEIDT, T. & KRONKE, M. (1992). Human 55-kDa receptor for tumor-necrosis-factor coupled to signal transduction cascades. J. Biol. Chem., 267, 1799718001.
  • WIEGMANN, K., SCHUTZE, S., MACHLEIDT, T., WITTE, D. & KRONKE, M. (1994). Functional dichotomy of neutral and acidic sphingomyelinases in tumour necrosis factor signaling. Cell, 78, 10051015.
  • WISSING, D., MOURITZEN, H., EGEBLAD, M., POIRIER, G.G. & JAATTELA, M. (1997). Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A., 94, 50735077.
  • WOJCIAK-STOTHARD, B., ENTWISTLE, A., GARG, R. & RIDLEY, A.J. (1998). Regulation of TNF-α-induced reorganization of the actin cytoskeleton and cell-cell Junctions by rho, rac, and cdc42 in human endothelial cells. J Cell Physiol, 176, 150165.
  • WONG, G.H.W., ELWELL, J.H., OBERLEY, L.W. & GOEDDEL, D.V. (1989). Manganous superoxide-dismutase is essential for cellular-resistance to cytotoxicity of tumor necrosis factor. Cell, 58, 923931.
  • WONG, G.H.W. & GOEDDEL, D.V. (1988). Induction of manganous superoxide-dismutase by tumor necrosis factor – possible protective mechanism. Science, 242, 941944.
  • WU, Y.L., JIANG, X.R., LILLINGTON, D.M., ALLEN, P.D., NEWLAND, A.C. & KELSEY, S.M. (1998a). 1,25-Dihydroxyvitamin D-3 protects human leukemic cells from tumor necrosis factor-induced apoptosis via inactivation of cytosolic phospholipase A2. Cancer Res., 58, 633640.
  • WU, Y.L., JIANG, X.R., NEWLAND, A.C. & KELSEY, S.M. (1998b). Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. J. Immunol., 160, 59295935.
  • WUYTS, W., VAN WESENBEECK, L., MORALES-PIGA, A., RALSTON, S., HOCKING, L., VANHOENACKER, F., WESTHOVENS, R., VERBRUGGEN, L., ANDERSON, D., HUGHES, A. & VAN HUL, W. (2001). Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone, 28, 104107.
  • XIA, Z., DICKENS, M., RAINGEAUD, J., DAVIS, R.J. & GREENBERG, M.E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 13261331.
  • YAN, F. & POLK, D.B. (2001). Kinase suppressor of ras is necessary for tumor necrosis factor α activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells. Cancer Res., 61, 963969.
  • YANAGA, F., ABE, M., KOGA, T. & HIRATA, M. (1992). Signal transduction by tumor-necrosis-factor-α is mediated through a guanine nucleotide-binding protein in osteoblast-like cell-line, MC3T3-E1. J. Biol. Chem., 267, 51145121.
  • YAO, B., ZHANG, Y.H., DELIKAT, S., MATHIAS, S., BASU, S. & KOLESNICK, R. (1995). Phosphorylation of raf by ceramide-activated protein-kinase. Nature, 378, 307310.
  • YEH, W.C., SHAHINIAN, A., SPEISER, D., KRAUNUS, J., BILLIA, F., WAKEHAM, A., DELAPOMPA, J.L., FERRICK, D., HUM, B., ISCOVE, N., OHASHI, P., ROTHE, M., GOEDDEL, D.V. & MAK, T.W. (1997). Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2- deficient mice. Immunity, 7, 715725.
  • YIN, L., WU, L., WESCHE, H., ARTHUR, C.D., WHITE, J.M., GOEDDEL, D.V. & SCHREIBER, R.D. (2001). Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice. Science, 291, 21622165.
  • YOREK, M., JAIPAUL, N., DUNLAP, J. & BIELEFELDT, K. (1999). Endothelin-stimulated Ca2+ mobilization by 3T3-L1 adipocytes is suppressed by tumor necrosis factor-α. Arch Biochem Biophys, 361, 241251.
  • YOUNG, P.R. (1998). Pharmacological modulation of cytokine action and production through signaling pathways. Cytokine Growth Factor Rev., 9, 239257.
  • YUASA, T., OHNO, S., KEHRL, J.H. & KYRIAKIS, J.M. (1998). Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38 – germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem., 273, 2268122692.
  • ZHANG, Y.H., YAO, B., DELIKAT, S., BAYOUMY, S., LIN, X.H., BASU, S., MCGINLEY, M., CHANHUI, P.Y., LICHENSTEIN, H. & KOLESNICK, R. (1997). Kinase suppressor of ras is ceramide-activated protein kinase. Cell, 89, 6372.
  • ZHENG, T.S., HUNOT, S., KUIDA, K. & FLAVELL, R.A. (1999). Caspase knockouts: matters of life and death. Cell Death Diff., 6, 10431053.
  • ZHOU, H.L., SUMMERS, S.K., BIRNBAUM, M.J. & PITTMAN, R.N. (1998). Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J. Biol. Chem., 273, 1656816575.
  • ZHOU, Q. & SALVESEN, G.S. (2000). Viral caspase inhibitors CrmA and p35. Apoptosis, 322, 143154.